Global Disintegrating Agent Market Size By Type (Dry Starch, Carboxymethyl Starch Sodium Carboxylate), By Application (Tablets, Capsules), By Region, And Segment Forecasts, 2023 to 2032

lobal Disintegrating Agent Market Report Description

The Global Disintegrating Agent Market was valued at USD 4.3 billion in 2023 and is projected to reach USD 7.1 billion by 2031, growing at a CAGR of 6.5% during the forecast period from 2023 to 2031. Disintegrating agents, essential in pharmaceutical and nutraceutical formulations, are gaining traction due to their critical role in ensuring rapid tablet breakdown and improved bioavailability. With increasing consumer demand for fast-acting drugs and the rise of orally disintegrating tablets (ODTs), the market is witnessing significant growth globally.

Drivers

Rising Demand for Orally Disintegrating Tablets (ODTs):

Consumer preference is shifting towards ODTs due to their convenience, especially among pediatric and geriatric populations. Disintegrating agents enhance tablet dissolution, making them vital to this growing drug delivery trend.

Expanding Pharmaceutical Industry in Emerging Economies:

Countries such as India, China, and Brazil are witnessing rapid pharmaceutical market growth. This expansion is driving demand for high-performance excipients like disintegrants.

Advancements in Disintegrant Formulations:

Ongoing R&D in excipient technology is producing superdisintegrants with superior swelling and wicking capabilities. These innovations enhance drug performance and are favored in high-speed manufacturing environments.

Restraints

High Cost of Advanced Disintegrants:

While superdisintegrants offer improved performance, their high production cost can deter smaller pharmaceutical manufacturers, particularly in cost-sensitive regions.

Stringent Regulatory Approvals:

Pharmaceutical excipients must comply with rigorous regulatory standards. Delays in approval processes can limit the market entry of novel disintegrant formulations.

Opportunity

Growing Nutraceutical and Dietary Supplement Sector:

With increasing global health consciousness, the nutraceutical industry is booming. Disintegrants are widely used in this sector, offering lucrative opportunities for manufacturers.

Customized Disintegration Solutions:

Tailored disintegrants for controlled-release, moisture-sensitive, and high-dose formulations are creating new avenues in advanced drug delivery systems.

Market by System Type Insights

Based on system type, the Superdisintegrants segment held the largest market share in 2023. These include sodium starch glycolate, crospovidone, and croscarmellose sodium, known for their superior efficiency in breaking down tablets. Their high compatibility with modern manufacturing processes makes them the preferred choice for rapid-release formulations.

Market by End-use Insights

The Pharmaceutical Industry emerged as the dominant end-use segment in 2023, accounting for over 70% of market share. The increasing demand for patient-centric dosage forms and faster therapeutic onset is driving the use of advanced disintegrants in pharma. Meanwhile, the Nutraceuticals segment is expected to grow at the fastest rate, fueled by rising global interest in dietary supplements.

Market by Regional Insights

Asia-Pacific led the global disintegrating agent market in 2023, driven by strong pharmaceutical production in India and China, increasing local demand, and favorable government policies supporting generic drug manufacturing. North America remains a vital region due to the high demand for innovative dosage forms and strict quality standards. Europe follows closely with its robust regulatory framework and growing geriatric population contributing to sustained demand for ODTs.

Competitive Scenario

Key players in the Global Disintegrating Agent Market include:

BASF SE

DuPont de Nemours, Inc.

Ashland Global Holdings Inc.

Roquette Frères

DFE Pharma

JRS Pharma

Asahi Kasei Corporation

Merck KGaA

Avantor, Inc.

SPI Pharma

These companies focus on R&D, strategic alliances, and geographical expansion to maintain a competitive edge. For example:

In 2023, Ashland launched a new multifunctional disintegrant for ODTs, combining rapid breakdown with enhanced taste-masking.

In 2024, BASF expanded its excipient production facility in Asia to meet growing regional demand.

Scope of Work – Global Disintegrating Agent Market

Key Market Developments

2023: DuPont introduced a novel disintegrant optimized for high-dose formulations, enhancing patient compliance.

2024: Roquette collaborated with a leading nutraceutical brand to supply clean-label disintegrants.

2025: DFE Pharma invested in a new R&D center in India to innovate bio-based disintegration solutions for sustainable pharma.

FAQs

1. What is the current market size of the Global Disintegrating Agent Market?

The market size in 2023 was valued at USD 4.3 billion.

2. What is the major growth driver of the Global Disintegrating Agent Market?

The primary growth driver is the increasing demand for orally disintegrating tablets (ODTs).

3. Which is the largest region during the forecast period in the Global Disintegrating Agent Market?

Asia-Pacific is the largest and fastest-growing region, supported by strong pharmaceutical manufacturing.

4. Which segment accounted for the largest market share in the Global Disintegrating Agent Market?

The Superdisintegrants segment held the largest market share in 2023.

5. Who are the key market players in the Global Disintegrating Agent Market?

Key players include BASF SE, DuPont, Ashland, Roquette, DFE Pharma, and JRS Pharma.

Let me know if you would like this formatted as a downloadable Word document or need visuals like charts or tables.